Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits.
Saved in:
| Title: | Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits. |
|---|---|
| Authors: | Alexander JF; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States., Seua AV; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States., Arroyo LD; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States., Ray PR; School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, Texas, United States., Wangzhou A; School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, Texas, United States., Heiβ-Lückemann L; Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Schedlowski M; Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Price TJ; School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, Texas, United States., Kavelaars A; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States., Heijnen CJ; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States. |
| Source: | Theranostics [Theranostics] 2021 Jan 01; Vol. 11 (7), pp. 3109-3130. Date of Electronic Publication: 2021 Jan 01 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33537077 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alexander+JF%22">Alexander JF</searchLink>; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States.<br /><searchLink fieldCode="AU" term="%22Seua+AV%22">Seua AV</searchLink>; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States.<br /><searchLink fieldCode="AU" term="%22Arroyo+LD%22">Arroyo LD</searchLink>; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States.<br /><searchLink fieldCode="AU" term="%22Ray+PR%22">Ray PR</searchLink>; School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, Texas, United States.<br /><searchLink fieldCode="AU" term="%22Wangzhou+A%22">Wangzhou A</searchLink>; School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, Texas, United States.<br /><searchLink fieldCode="AU" term="%22Heiβ-Lückemann+L%22">Heiβ-Lückemann L</searchLink>; Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Schedlowski+M%22">Schedlowski M</searchLink>; Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Price+TJ%22">Price TJ</searchLink>; School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, Texas, United States.<br /><searchLink fieldCode="AU" term="%22Kavelaars+A%22">Kavelaars A</searchLink>; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States.<br /><searchLink fieldCode="AU" term="%22Heijnen+CJ%22">Heijnen CJ</searchLink>; Laboratories of Neuroimmunology, Department of Symptom Research, Division of Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101552395%22">Theranostics</searchLink> [Theranostics] 2021 Jan 01; Vol. 11 (7), pp. 3109-3130. <i>Date of Electronic Publication: </i>2021 Jan 01 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101552395 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1838-7640 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218387640%22">18387640 </searchLink><i>NLM ISO Abbreviation: </i>Theranostics <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33537077 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7150/thno.53474 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3109 Titles: – TitleFull: Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alexander JF – PersonEntity: Name: NameFull: Seua AV – PersonEntity: Name: NameFull: Arroyo LD – PersonEntity: Name: NameFull: Ray PR – PersonEntity: Name: NameFull: Wangzhou A – PersonEntity: Name: NameFull: Heiβ-Lückemann L – PersonEntity: Name: NameFull: Schedlowski M – PersonEntity: Name: NameFull: Price TJ – PersonEntity: Name: NameFull: Kavelaars A – PersonEntity: Name: NameFull: Heijnen CJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2021 Jan 01 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1838-7640 Numbering: – Type: volume Value: 11 – Type: issue Value: 7 Titles: – TitleFull: Theranostics Type: main |
| ResultId | 1 |